CAR-T in Estonia: Hemogenyx Pharmaceuticals signed a definitive deal with Estonian Cellin Technologies to manufacture and implement its HG-CT-1 CAR-T therapy for relapsed/refractory acute myeloid leukemia under Estonia’s Hospital Exemption pathway, aiming for near-term revenue and possible reimbursement via the Health Insurance Fund. Long COVID & chronic disease links (Estonia): Tartu researchers using nearly 210,000 Estonian Biobank donors report a two-way connection: chronic illnesses can prolong long COVID, while long COVID is linked to more new diagnoses such as sleep apnea and heart rhythm disorders. Tick-borne risk: Estonia’s Health Board data and local ecology experts point to rising Lyme disease bacteria in ticks this summer, with practical prevention tips like avoiding tick bites and supporting natural tick predators in gardens. Mental health literacy (Estonia): An umbrella review led by TAI highlights that Estonia’s mental health literacy research often focuses on disorders and stigma, but should also teach everyday skills that support well-being. Hepatitis C progress (UK, relevant for Estonia-born groups): NHS England says it’s “on the cusp” of eliminating hepatitis C, with 100,000+ people treated since 2015 and free home testing urged for people at higher risk, including adults born in Estonia and other Eastern European countries. Wellness & daily support: An Estonian “Fresh Start for the Home” cleaner describes helping people with depression, ADHD and other mental health challenges by tackling clutter with practical, supportive organizing. Phage therapy trial (EU): A €15m EU-backed international trial (P-PEAKS UTI) will test personalized bacteriophage therapy to prevent recurrent drug-resistant UTIs in women.